The CDMO business will be structured into three new business platforms designed to create a unified organization: Integrated Biologics, Advanced Synthesis, and Specialized Modalities
EBITDA for the quarter is Rs. 21.6 crore as against Rs. 18.1 crore in Q2 FY24
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studies
Strengthening focus in Alzheimer's disease and neuroscience pipeline
He has more than 25 years of experience in manufacturing across various industries including petrochemicals, engineering polymers, agrochemicals, organic, and inorganic intermediates
This partnership will enable healthcare organizations to provide best-in-class patient/consumer experiences
Professor G. D. Yadav is one of India’s most prolific and accomplished engineering-scientists, holding the prestigious National Science Chair from the Government of India
Transform healthcare by integrating expertise from AI, clinical sciences, and basic sciences to harness India’s extensive data sets for improving the access to healthcare
TTP Group is a leading engineering firm specializing in biotech and pharmaceutical industry
eGenesis is pioneering a genome engineering-based approach in the development of safe and effective transplantable organs to end the global organ shortage
Subscribe To Our Newsletter & Stay Updated
